跳至主要内容
临床试验/TCTR20190509004
TCTR20190509004已完成未知

Efficacy of Submucosal Tramadol and Lidocaine on Success Rate of Inferior Alveolar Nerve Block in Mandibular Molars with Symptomatic Irreversible Pulpitis: A Randomized, Controlled, Double-Blind Clinical Study

none0 个研究点目标入组 105 人开始时间: 2019年5月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • 1. A single mandibular molar tooth responding to cold test for a long time and diagnosed with symptomatic irreversible pulpitis
  • 2. Patients with preoperative pain scores ranging from moderate to severe (55â€170 mm) on a Heft-Parker visual analog scale (HP VAS, 0â€170 mm)
  • 3. The absence of periapical radiolucency on periapical radiography (except enlarged periodontal ligaments not larger than 0.75-1 mm)
  • 4. Have the ability to understand the informed consent form and pain record scales to be used within the study

排除标准

  • 1. Receiving analgesic or anti-inflammatory drugs within 24 hours prior to treatment
  • 2. Allergy or susceptibility to any opioid or nonopioid analgesia, including lidocaine, tramadol or NSAIDs
  • 3. Pregnant or nursing, those with any bleeding problem or those using anticoagulant medication
  • 4. Patients have not lip numbness following initial IANB injection
  • 4. In addition to hypersensitive teeth to percussion and palpation; teeth have calcified root canals, periodontal diseases, root resorption, open apex, necrotic pulp and have already been undergone root canal treatment were excluded from the study.

研究者

发起方
none

相似试验